Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Chiodo

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
AIDS (London, England)|September 23, 2003
Rituximab alone proves effective in the treatment of refractory, severe stage III AIDS-related non-Hodgkin's paediatric lymphomaRoberto Manfredi, Marina Tadolini, Lorenza Fortunato, et al.
Current HIV Research|November 11, 2008
Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesterolaemia in HIV-infected patients receiving protease inhibitorsLeonardo Calza, Roberto Manfredi, Vincenzo Colangeli, et al.
BMC Medical Informatics and Decision Making|July 2, 2025
Computational modeling of infectious diseases: insights from network-based simulations on measlesFrancesco Branda, Pierangelo Veltri, Francesco Chiodo, et al.
Recenti Progressi in Medicina|July 19, 2003
[Nosocomial methicillin-resistant staphylococci that remain sensitive to non-beta lactam antibiotics]Roberto Manfredi, Anna Nanetti, Samanta Morelli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 5, 2003
Bone mass in HIV-infected patients: focus on the role of therapy and sexFabio Vescini, Marco Borderi, Angela Buffa, et al.
The New Microbiologica|July 8, 2009
Paradoxical immune reconstitution inflammatory syndrome associated with previous Cryptococcus neoformans infection in an HIV-positive patient requiring neurosurgical interventionCarlo Biagetti, Monica Nicola, Marco Borderi, et al.
AIDS (London, England)|June 17, 2005
Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot studyLeonardo Calza, Vincenzo Colangeli, Roberto Manfredi, et al.
HIV Clinical Trials|October 9, 2004
A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infectionRoberto Manfredi, Anna Nanetti, Samanta Morelli, et al.
AIDS (London, England)|June 17, 2005
Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemiaLeonardo Calza, Roberto Manfredi, Vincenzo Colangeli, et al.
Recenti Progressi in Medicina|February 18, 2003
[Reduction of antibiotic resistance of Enterococcus faecalis in infections of the genitourinary tract]Roberto Manfredi, Anna Nanetti, Roberta Valentini, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
AIDS (London, England)|September 23, 2003
Rituximab alone proves effective in the treatment of refractory, severe stage III AIDS-related non-Hodgkin's paediatric lymphomaRoberto Manfredi, Marina Tadolini, Lorenza Fortunato, et al.
Current HIV Research|November 11, 2008
Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesterolaemia in HIV-infected patients receiving protease inhibitorsLeonardo Calza, Roberto Manfredi, Vincenzo Colangeli, et al.
BMC Medical Informatics and Decision Making|July 2, 2025
Computational modeling of infectious diseases: insights from network-based simulations on measlesFrancesco Branda, Pierangelo Veltri, Francesco Chiodo, et al.
Recenti Progressi in Medicina|July 19, 2003
[Nosocomial methicillin-resistant staphylococci that remain sensitive to non-beta lactam antibiotics]Roberto Manfredi, Anna Nanetti, Samanta Morelli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 5, 2003
Bone mass in HIV-infected patients: focus on the role of therapy and sexFabio Vescini, Marco Borderi, Angela Buffa, et al.
The New Microbiologica|July 8, 2009
Paradoxical immune reconstitution inflammatory syndrome associated with previous Cryptococcus neoformans infection in an HIV-positive patient requiring neurosurgical interventionCarlo Biagetti, Monica Nicola, Marco Borderi, et al.
AIDS (London, England)|June 17, 2005
Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot studyLeonardo Calza, Vincenzo Colangeli, Roberto Manfredi, et al.
HIV Clinical Trials|October 9, 2004
A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infectionRoberto Manfredi, Anna Nanetti, Samanta Morelli, et al.
AIDS (London, England)|June 17, 2005
Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemiaLeonardo Calza, Roberto Manfredi, Vincenzo Colangeli, et al.
Recenti Progressi in Medicina|February 18, 2003
[Reduction of antibiotic resistance of Enterococcus faecalis in infections of the genitourinary tract]Roberto Manfredi, Anna Nanetti, Roberta Valentini, et al.
Pageof 11